On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Orion Oyj's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€93k · 12 projects
- Horizon 2020€49k · 6 projects
- Horizon Europe€0 · 8 projects
Projects
26 EU-funded projects, newest first. Each links to the official record.
- RESDOCAssociated partner
Training Doctoral Excellence for Resilient and Just Future
Horizon Europe · 2027–2031 · Project on CORDIS ↗
- SciLifeLab PULSEAssociated partner
SciLifeLab Programme for fUture Leaders in life SciencE
Horizon Europe · 2025–2030 · Project on CORDIS ↗
- IMMUFELLOWAssociated partner
Interdisciplinary and Intersectoral Research Fellowship Program for Future Leaders in Immunology
Horizon Europe · 2025–2030 · Project on CORDIS ↗
- HAIFAssociated partner
Human-Centric Artificial Intelligence for Sustainable Future
Horizon Europe · 2025–2029 · Project on CORDIS ↗
- NOVELAssociated partner
Novel brain health solutions across four focus areas: Prevention and care, Methods and data, Innovation and society, and Ethics and well-being
Horizon Europe · 2024–2029 · Project on CORDIS ↗
- VICT3RPartner
Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research
Horizon Europe · 2024–2028 · Project on CORDIS ↗
- ETERNITYAssociated partner
FuEl ThE bRaiN In healtThY aging and agE-relateD diseases
Horizon Europe · 2023–2027 · Project on CORDIS ↗
- TransPharmPartner
Transforming into a sustainable European pharmaceutical sector
Horizon Europe · 2022–2026 · Project on CORDIS ↗
- IDEA-FASTPartner
Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases
Horizon 2020 · 2019–2026 · Project on CORDIS ↗
- PIONEERPartner
Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope
Horizon 2020 · 2018–2023 · Project on CORDIS ↗
- TransQSTPartner
Translational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030
Horizon 2020 · 2017–2022 · Project on CORDIS ↗
- TreatERPartner
Clinical study in Parkinson's disease with two unique goals: 1) Proof-of-concept of CDNF protein for disease modification; 2) Validation of clinically tested device for intracerebral drug delivery
Horizon 2020 · 2017–2020 · Project on CORDIS ↗
€49ktheir share - PHAGOPartner
Inflammation and AD: modulating microglia function focussing on TREM2 and CD33 - Sofia ref.: 115976
Horizon 2020 · 2016–2022 · Project on CORDIS ↗
- CANCER-IDPartner
Cancer treatment and monitoring through identification of circulating tumour cells and tumour related nucleic acids in blood
FP7 (2007 to 2013) · 2015–2019 · Project on CORDIS ↗
- CHEM21Partner
Chemical Manufacturing Methods for the 21st Century Pharmaceutical Industries
FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗
- STEMBANCCPartner
Stem cells for Biological Assays of Novel drugs and prediCtive toxiCology (StemBANCC)
FP7 (2007 to 2013) · 2012–2018 · Project on CORDIS ↗
- MIP-DILIPartner
Mechanism-Based Integrated Systems for the Prediction of Drug-Induced Liver Injury
FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗
- PREDECTPartner
New Models for Preclinical Evaluation of Drug Efficacy in Common Solid Tumours
FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗
- SAFESCIMETPartner
European Modular Education and Training Programme in Safety Sciences for Medicines
FP7 (2007 to 2013) · 2010–2016 · Project on CORDIS ↗
- EMTRAINPartner
European Medicines Research Training Network
FP7 (2007 to 2013) · 2009–2016 · Project on CORDIS ↗
- NEWMEDSPartner
Novel Methods leading to New Medications in Depression and Schizophrenia
FP7 (2007 to 2013) · 2009–2015 · Project on CORDIS ↗
- EU2PPartner
European programme in Pharmacovigilance and Pharmacoepidemiology
FP7 (2007 to 2013) · 2009–2016 · Project on CORDIS ↗
- PHARMATRAINPartner
Pharmaceutical Medicine Training Programme
FP7 (2007 to 2013) · 2009–2014 · Project on CORDIS ↗
- PROSPERPartner
Prostate cancer: profiling and evaluation of ncRNA
FP7 (2007 to 2013) · 2008–2012 · Project on CORDIS ↗
€93ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Janssen Pharmaceutica NVBelgium · 15 shared projects
- Astrazeneca ABSweden · 14 shared projects
- F. Hoffmann-La Roche AGSwitzerland · 11 shared projects
- Sanofi-Aventis Recherche & DeveloppementFrance · 11 shared projects
- Boehringer Ingelheim InternationalgmbhGermany · 10 shared projects
- Glaxosmithkline Research & Development LimitedUnited Kingdom · 9 shared projects
- Eli Lilly and Company LtdUnited Kingdom · 9 shared projects
- Pfizer LimitedUnited Kingdom · 9 shared projects
- Karolinska InstitutetSweden · 8 shared projects
- Novartis Pharma AGSwitzerland · 8 shared projects
- H. Lundbeck ASDenmark · 8 shared projects
- Erasmus Universitair Medisch Centrum RotterdamNetherlands · 7 shared projects
- The University of ManchesterUnited Kingdom · 6 shared projects
- King'S College LondonUnited Kingdom · 6 shared projects
- Charite - Universitaetsmedizin BerlinGermany · 6 shared projects
- Turun YliopistoFinland · 6 shared projects
Fields it works in
Research fields recorded on its Horizon projects.
- RNA
- adverse drug reactions
- alzheimer
- artificial intelligence
- biocatalysis
- bioreactors
- breast cancer
- business models
- cardiac arrhythmia
- cell biology
- cognitive neuroscience
- crystals
- data science
- databases
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗
